← Back to Search

eScreen system for Post-Traumatic Stress Disorder

N/A
Waitlist Available
Led By Nancy Kassam-Adams, PhD
Research Sponsored by Children's Hospital of Philadelphia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Child treated or admitted for injury or illness event that occurred within the past month
Child has regular access to a compatible (IOS or Android) tablet at home
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 weeks
Awards & highlights

Study Summary

This trial will help researchers understand if a game-based assessment system can help predict a child's recovery from an injury.

Eligible Conditions
  • Post-Traumatic Stress Disorder
  • Pain

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Predictive validity of eScreen pain measure for clinically significant pain interference at 6 weeks
Predictive validity of eScreen pain measure for clinically significant pain severity at 6 weeks
Predictive validity of eScreen posttraumatic stress measure for clinically significant posttraumatic stress symptoms at 6 weeks
+1 more
Secondary outcome measures
Impact of eScreen system on parent confidence in managing child symptoms and recovery

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: eScreen GroupExperimental Treatment1 Intervention
After randomization at baseline, use eScreen system (child screening component and parent information component) for 6 weeks.
Group II: Usual Care GroupActive Control1 Intervention
Treatment as usual from baseline. Optional access to the game only (no screening, no parent information component) after completion of T3 assessment (~12 weeks)
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
eScreen system
2021
N/A
~340

Find a Location

Who is running the clinical trial?

Children's Hospital of PhiladelphiaLead Sponsor
707 Previous Clinical Trials
8,580,959 Total Patients Enrolled
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH
1,959 Previous Clinical Trials
2,673,308 Total Patients Enrolled
University of KentuckyOTHER
185 Previous Clinical Trials
226,310 Total Patients Enrolled

Frequently Asked Questions

~80 spots leftby Apr 2025